Public market insider buying at Profound Medical (PRN)

Public market insider buying at Profound Medical (T:PRN)

Arun Menawat, CEO and Director, acquired 30,000 Common Shares on a direct ownership basis at a price of $6.924USD on May 13th, 2022. This represents a $269,040 investment into the company's shares and an account share holdings change of 7.9%.

Profound Medical is in the Advanced Medical Equipment & Technology Sub Industry Group under the Healthcare Sector.